Publications by authors named "S Sigala"
Article Synopsis
- Filamin A (FLNA) is found at lower levels in adrenocortical carcinomas (ACC) compared to adenomas (ACA), and its presence is linked to less aggressive tumor behavior due to its role in regulating IGF1R signaling.
- The study investigated the expression of Wee1 kinase in ACC and how it is influenced by FLNA, revealing increased Wee1 and decreased FLNA proteins in ACC, along with insights into the effects of the Wee1 inhibitor AZD1775.
- Findings indicate that FLNA promotes the degradation of Wee1, and that low FLNA levels in ACC lead to heightened Wee1, suggesting that targeting Wee1 with inhibitors could be a promising treatment strategy for FLNA-deficient
Disruption of processes involved in tissue development and homeostatic self-renewal is increasingly implicated in cancer initiation, progression, and recurrence. The adrenal cortex is a dynamic tissue that undergoes life-long turnover. Here, using genetic fate mapping and murine adrenocortical carcinoma (ACC) models, we have identified a population of adrenocortical stem cells that express delta-like non-canonical Notch ligand 1 (DLK1).
View Article and Find Full Text PDFUnlabelled: Adrenocortical carcinoma (ACC) is a rare and highly heterogeneous disease with a notably poor prognosis due to significant challenges in diagnosis and treatment. Emphasizing on the importance of precision medicine, there is an increasing need for comprehensive genomic resources alongside well-developed experimental models to devise personalized therapeutic strategies. We present ACC_CellMinerCDB, a substantive genomic and drug sensitivity database (available at https://discover.
View Article and Find Full Text PDFBackground: Adrenocortical carcinoma (ACC) is a rare cancer that arises sporadically or due to hereditary syndromes. Data on germline variants (GVs) in sporadic ACC are limited. Our aim was to characterize GVs of genes potentially related to adrenal diseases in 150 adult patients with sporadic ACC.
View Article and Find Full Text PDFBackground: Most patients with testicular germ cell tumors (GCTs) are treated with cisplatin (CP)-based chemotherapy. However, some of them may develop CP resistance and therefore represent a clinical challenge. Cyclin-dependent kinase 5 (CDK5) is involved in chemotherapy resistance in different types of cancer.
View Article and Find Full Text PDF